Almitas Capital »

Tekla Life Sciences sh ben int shares owned by Almitas Capital

Quarter-by-quarter ownership of Tekla Life Sciences sh ben int (HQL) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Tekla Life Sciences sh ben int

Tip: Access up to 7 years of quarterly data

All positions including Tekla Life Sciences sh ben int held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tekla Life Sciences sh ben int by Almitas Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $323k 19k 16.78

More positions owned by Almitas Capital

Fidelity Wise Origin Bitcoin SHS (FBTC)
Blackrock Mun Target Term Tr Com Shs Ben In (BTT)
Amylyx Pharmaceuticals (AMLX)
Asa Gold And Precious Mtls L SHS (ASA)
Fidelity Ethereum SHS (FETH)
Lyell Immunopharma Com New (LYEL)
Elme Communities Sh Ben Int (ELME)
Design Therapeutics (DSGN)
Fs Specialty Lending Com Sh Ben Int (FSSL)
Cannae Holdings (CNNE)
Monroe Cap (MRCC)
Crescent Capital Bdc (CCAP)
Brightspire Capital Com Cl A (BRSP)
Bny Mellon Strategic Municipal Bond Fund closed end income funds non-taxable (DSM)
Pimco CA Municipal Income Fund (PCQ)

View all positions for Almitas Capital

Top funds holding Tekla Life Sciences sh ben int

Saba Capital Management
Penserra Capital Management
LPL Financial
Raymond James Financial
Needham Investment Management
Flagship Harbor Advisors
Rivernorth Capital Management
Allspring Global Investments Holdings
Ameriprise Financial
Advisors Asset Management
180 Wealth Advisors
BBK Capital Partners
1607 Capital Partners
Shaker Financial Services
Pensionmark Financial Group

View all funds holding Tekla Life Sciences sh ben int